Stroke prevention using dabigatran in elderly Chinese patients with atrial fibrillation

Heart Rhythm

Volumn 13, Issue 2, 2016, Pages 366-373

  Chan, Pak Hei ^a   Huang, Duo ^a   Hai, Jo Jo ^a   Li, Wen Hua ^a,b   Yin, Li Xue ^b   Chan, Esther W ^a   Wong, Ian C K ^a   Lau, Chu Pak ^a   Chiang, Chern En ^c   Zhu, Jun ^d   Tse, Hung Fat ^a   Siu, Chung Wah ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d FUWAI HOSPITAL   (China)

Author keywords

Atrial fibrillation; Chinese; Dabigatran; Elderly

Indexed keywords

DABIGATRAN; WARFARIN; ANTICOAGULANT AGENT;

AGED; ARTICLE; ATRIAL FIBRILLATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NONVALVULAR ATRIAL FIBRILLATION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; TRANSIENT ISCHEMIC ATTACK; VERY ELDERLY; CHEMICALLY INDUCED; CHINA; COMPLICATION; INTRACRANIAL HEMORRHAGES; OUTCOME ASSESSMENT; STROKE;

AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CHINA; DABIGATRAN; FEMALE; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; OUTCOME ASSESSMENT (HEALTH CARE); STROKE; WARFARIN;

EID: 84955735163     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2015.09.015     Document Type: Article

References (36)

1. G.Y. Lip, H.F. Tse, and D.A. Lane Atrial fibrillation Lancet 379 2012 648 661
2. R.G. Hart, L.A. Pearce, and M.I. Aguilar Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann Intern Med 146 2007 857 867
3. A.J. Camm, G.Y. Lip, R. De Caterina, I. Savelieva, D. Atar, S.H. Hohnloser, G. Hindricks, and P. Kirchhof ESC Committee for Practice Guidelines (CPG). 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association Eur Heart J 33 2012 2719 2747
4. C.T. January, L.S. Wann, J.S. Alpert, and et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society Circulation 130 2014 2071 2104
5. R.G. Hart, B.S. Boop, and D.C. Anderson Oral anticoagulants and intracranial hemorrhage: facts and hypotheses Stroke 26 1995 1471 1477
6. L. Friberg, M. Rosenqvist, and G.Y. Lip Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study Eur Heart J 33 2012 1500 1510
7. J. Mant, F.D. Hobbs, K. Fletcher, A. Roalfe, D. Fitzmaurice, G.Y. Lip, and E. Murray Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial Lancet 370 2007 493 503
8. Q.D. Yang, Q. Niu, Y.H. Zhou, Y.H. Liu, H.W. Xu, W.P. Gu, F.F. Tian, Y.Q. Xie, L. Zhang, and J. Xia Incidence of cerebral hemorrhage in the Changsha community: a prospective study from 1986 to 2000 Cerebrovasc Dis 17 2004 303 313
9. L.F. Zhang, J. Yang, Z. Hong, G.G. Yuan, B.F. Zhou, L.C. Zhao, Y.N. Huang, J. Chen, and Y.F. Wu Proportion of different subtypes of stroke in China Stroke 34 2003 2091 2096
10. C.W. Siu, and H.F. Tse Net clinical benefit of warfarin therapy in elderly Chinese patients with atrial fibrillation Circ Arrhythm Electrophysiol 7 2014 300 306
11. P.H. Chan, J.J. Hai, and C.W. Siu Response to letter regarding article, "Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control." Stroke 46 2015 e72
12. K.C. Teo, N.R. Mahboobani, R. Lee, C.W. Siu, R.T. Cheung, S.L. Ho, K.K. Lau, and K.H. Chan Warfarin associated intracerebral hemorrhage in Hong Kong Chinese Neurol Res 36 2014 143 149
13. C.W. Siu One more "C" for CHA2DS2-VASc score? J Am Coll Cardiol 65 2015 1602 1603
14. D.C. McCrory, D.B. Matchar, G. Samsa, L.L. Sanders, and E.L. Pritchett Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly Archiv Intern Med 155 1995 277 281
15. G.Y. Lip, K. Wang, and C. Chiang Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: time for a reappraisal Int J Cardiol 180 2015 246 254
16. C.W. Siu, M.H. Jim, H.H. Ho, R. Miu, S.W. Lee, C.P. Lau, and H.F. Tse Transient atrial fibrillation complicating acute inferior myocardial infarction: implications for future risk of ischemic stroke Chest 132 2007 44 49
17. C.W. Siu, M.H. Jim, X. Zhang, Y.H. Chan, V. Pong, J. Kwok, A.W. Kung, C.P. Lau, and H.F. Tse Comparison of atrial fibrillation recurrence rates after successful electrical cardioversion in patients with hyperthyroidism-induced versus non-hyperthyroidism-induced persistent atrial fibrillation Am J Cardiol 103 2009 540 543
18. C.W. Siu, V. Pong, X. Zhang, Y.H. Chan, M.H. Jim, S. Liu, K.H. Yiu, A.W. Kung, C.P. Lau, and H.F. Tse Risk of ischemic stroke after new-onset atrial fibrillation in patients with hyperthyroidism Heart Rhythm 6 2009 169 173
19. C.C. Lam, H.F. Tse, and C.W. Siu Transient atrial fibrillation complicating acute myocardial infarction: a nuisance or a nemesis? Thromb Haemost 107 2012 6 7
20. L. Friberg, M. Rosenqvist, and G.Y. Lip Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study Circulation 125 2012 2298 2307
21. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation Chest 137 2010 263 272
22. R. Pisters, D.A. Lane, R. Nieuwlaat, C.B. de Vos, H.J. Crijns, and G.Y. Lip A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey Chest 138 2010 1093 1100
23. F.R. Rosendaal, S.C. Cannegieter, F.J. van der Meer, and E. Briet A method to determine the optimal intensity of oral anticoagulant therapy Thromb Haemost 69 1993 236 239
24. E.C. Jauch, J.L. Saver, H.P. Adams Jr, and et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke 44 2013 870 947
25. K.H. Chan, G. Ka-Kit Leung, K.K. Lau, S. Liu, W.M. Lui, C.P. Lau, H.F. Tse, P.u.J. Kan-Suen, and C.W. Siu Predictive value of the HAS-BLED score for the risk of recurrent intracranial hemorrhage after first spontaneous intracranial hemorrhage World Neurosurg 82 2014 e219 e223
26. V. Pong, K.H. Chan, B.H. Chong, W.M. Lui, G.K. Leung, H.F. Tse, J.K. Pu, and C.W. Siu Long-term outcome and prognostic factors after spontaneous cerebellar hemorrhage Cerebellum 11 2012 939 945
27. S.J. Connolly, M.D. Ezekowitz, S. Yusuf, and et al. Dabigatran versus warfarin in patients with atrial fibrillation New Engl J Med 361 2009 1139 1151
28. M.R. Patel, K.W. Mahaffey, J. Garg, and et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation New Engl J Med 365 2011 883 891
29. C.B. Granger, J.H. Alexander, J.J.V. McMurray, and et al. Apixaban versus warfarin in patients with atrial fibrillation New Engl J Med 365 2011 981 992
30. C.Y. Huang, F.L. Chan, Y.L. Yu, E. Woo, and D. Chin Cerebrovascular disease in Hong Kong Chinese Stroke 21 1990 230 235
31. P. Harper, L. Young, and E. Merriman Bleeding risk with dabigatran in the frail elderly New Engl J Med 366 2012 864 866
32. H.T. Chan, L.T. So, S.W. Li, C.W. Siu, C.P. Lau, and H.F. Tse Effect of herbal consumption on time in therapeutic range of warfarin therapy in patients with atrial fibrillation J Cardiovasc Pharmacol 58 2011 87 90
33. L.Y. Ho, C.W. Siu, W.S. Yue, C.P. Lau, G.Y. Lip, and H.F. Tse Safety and efficacy of oral anticoagulation therapy in Chinese patients with concomitant atrial fibrillation and hypertension J Hum Hypertens 25 2011 304 310
34. H.F. Tse, Y.J. Wang, M. Ahmed Ai-Abdullah, and et al. Stroke prevention in atrial fibrillation - an Asian stroke perspective Heart Rhythm 10 2013 1082 1088
35. P.A. Reilly, T. Lehr, S. Haertter, S.J. Connolly, S. Yusuf, J.W. Eikelboom, M.D. Ezekowitz, G. Nehmiz, S. Wang, and L. Wallentin The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy) J Am Coll Cardiol 63 2014 321 328
36. M. Hori, T. Fukaya, E. Kleine, P.A. Reilly, M.D. Ezekowitz, and S.J. Connolly RE-LY Investigators. Efficacy and safety of dabigatran etexilate vs. warfarin in Asian RE-LY patients according to baseline renal function or CHADS2 score Circ J 79 2015 2138 2147